Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study
• 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially red...
Ausführliche Beschreibung
Autor*in: |
Laprise, Jean-François [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement - Li, Yaoyao ELSEVIER, 2022, Amsterdam |
---|---|
Übergeordnetes Werk: |
volume:32 ; year:2014 ; number:44 ; day:7 ; month:10 ; pages:5845-5853 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.vaccine.2014.07.099 |
---|
Katalog-ID: |
ELV022588477 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV022588477 | ||
003 | DE-627 | ||
005 | 20230623164301.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2014.07.099 |2 doi | |
028 | 5 | 2 | |a GBVA2014008000005.pica |
035 | |a (DE-627)ELV022588477 | ||
035 | |a (ELSEVIER)S0264-410X(14)01081-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 630 |a 640 |q VZ |
084 | |a 48.00 |2 bkl | ||
100 | 1 | |a Laprise, Jean-François |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study |
264 | 1 | |c 2014 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. | ||
650 | 7 | |a Anogenital warts |2 Elsevier | |
650 | 7 | |a Immunisation |2 Elsevier | |
650 | 7 | |a Human papillomavirus (HPV) |2 Elsevier | |
650 | 7 | |a Vaccine schedules |2 Elsevier | |
650 | 7 | |a Transmission-dynamic modelling |2 Elsevier | |
650 | 7 | |a Programme optimisation |2 Elsevier | |
650 | 7 | |a Cost-effectiveness |2 Elsevier | |
650 | 7 | |a Cervical cancer |2 Elsevier | |
700 | 1 | |a Drolet, Mélanie |4 oth | |
700 | 1 | |a Boily, Marie-Claude |4 oth | |
700 | 1 | |a Jit, Mark |4 oth | |
700 | 1 | |a Sauvageau, Chantal |4 oth | |
700 | 1 | |a Franco, Eduardo L. |4 oth | |
700 | 1 | |a Lemieux-Mellouki, Philippe |4 oth | |
700 | 1 | |a Malagón, Talía |4 oth | |
700 | 1 | |a Brisson, Marc |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Li, Yaoyao ELSEVIER |t Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |d 2022 |g Amsterdam |w (DE-627)ELV007884451 |
773 | 1 | 8 | |g volume:32 |g year:2014 |g number:44 |g day:7 |g month:10 |g pages:5845-5853 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.vaccine.2014.07.099 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OPC-FOR | ||
936 | b | k | |a 48.00 |j Land- und Forstwirtschaft: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 32 |j 2014 |e 44 |b 7 |c 1007 |h 5845-5853 |g 9 | ||
953 | |2 045F |a 610 |
author_variant |
j f l jfl |
---|---|
matchkey_str |
laprisejeanfranoisdroletmlanieboilymarie:2014----:oprnteotfetvnsotontreoeceueohmnailmvrsacntoar |
hierarchy_sort_str |
2014 |
bklnumber |
48.00 |
publishDate |
2014 |
allfields |
10.1016/j.vaccine.2014.07.099 doi GBVA2014008000005.pica (DE-627)ELV022588477 (ELSEVIER)S0264-410X(14)01081-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 VZ 48.00 bkl Laprise, Jean-François verfasserin aut Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Elsevier Drolet, Mélanie oth Boily, Marie-Claude oth Jit, Mark oth Sauvageau, Chantal oth Franco, Eduardo L. oth Lemieux-Mellouki, Philippe oth Malagón, Talía oth Brisson, Marc oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 https://doi.org/10.1016/j.vaccine.2014.07.099 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 32 2014 44 7 1007 5845-5853 9 045F 610 |
spelling |
10.1016/j.vaccine.2014.07.099 doi GBVA2014008000005.pica (DE-627)ELV022588477 (ELSEVIER)S0264-410X(14)01081-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 VZ 48.00 bkl Laprise, Jean-François verfasserin aut Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Elsevier Drolet, Mélanie oth Boily, Marie-Claude oth Jit, Mark oth Sauvageau, Chantal oth Franco, Eduardo L. oth Lemieux-Mellouki, Philippe oth Malagón, Talía oth Brisson, Marc oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 https://doi.org/10.1016/j.vaccine.2014.07.099 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 32 2014 44 7 1007 5845-5853 9 045F 610 |
allfields_unstemmed |
10.1016/j.vaccine.2014.07.099 doi GBVA2014008000005.pica (DE-627)ELV022588477 (ELSEVIER)S0264-410X(14)01081-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 VZ 48.00 bkl Laprise, Jean-François verfasserin aut Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Elsevier Drolet, Mélanie oth Boily, Marie-Claude oth Jit, Mark oth Sauvageau, Chantal oth Franco, Eduardo L. oth Lemieux-Mellouki, Philippe oth Malagón, Talía oth Brisson, Marc oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 https://doi.org/10.1016/j.vaccine.2014.07.099 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 32 2014 44 7 1007 5845-5853 9 045F 610 |
allfieldsGer |
10.1016/j.vaccine.2014.07.099 doi GBVA2014008000005.pica (DE-627)ELV022588477 (ELSEVIER)S0264-410X(14)01081-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 VZ 48.00 bkl Laprise, Jean-François verfasserin aut Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Elsevier Drolet, Mélanie oth Boily, Marie-Claude oth Jit, Mark oth Sauvageau, Chantal oth Franco, Eduardo L. oth Lemieux-Mellouki, Philippe oth Malagón, Talía oth Brisson, Marc oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 https://doi.org/10.1016/j.vaccine.2014.07.099 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 32 2014 44 7 1007 5845-5853 9 045F 610 |
allfieldsSound |
10.1016/j.vaccine.2014.07.099 doi GBVA2014008000005.pica (DE-627)ELV022588477 (ELSEVIER)S0264-410X(14)01081-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 VZ 48.00 bkl Laprise, Jean-François verfasserin aut Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Elsevier Drolet, Mélanie oth Boily, Marie-Claude oth Jit, Mark oth Sauvageau, Chantal oth Franco, Eduardo L. oth Lemieux-Mellouki, Philippe oth Malagón, Talía oth Brisson, Marc oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 https://doi.org/10.1016/j.vaccine.2014.07.099 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 32 2014 44 7 1007 5845-5853 9 045F 610 |
language |
English |
source |
Enthalten in Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement Amsterdam volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 |
sourceStr |
Enthalten in Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement Amsterdam volume:32 year:2014 number:44 day:7 month:10 pages:5845-5853 extent:9 |
format_phy_str_mv |
Article |
bklname |
Land- und Forstwirtschaft: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Anogenital warts Immunisation Human papillomavirus (HPV) Vaccine schedules Transmission-dynamic modelling Programme optimisation Cost-effectiveness Cervical cancer |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
authorswithroles_txt_mv |
Laprise, Jean-François @@aut@@ Drolet, Mélanie @@oth@@ Boily, Marie-Claude @@oth@@ Jit, Mark @@oth@@ Sauvageau, Chantal @@oth@@ Franco, Eduardo L. @@oth@@ Lemieux-Mellouki, Philippe @@oth@@ Malagón, Talía @@oth@@ Brisson, Marc @@oth@@ |
publishDateDaySort_date |
2014-01-07T00:00:00Z |
hierarchy_top_id |
ELV007884451 |
dewey-sort |
3610 |
id |
ELV022588477 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022588477</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164301.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.vaccine.2014.07.099</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014008000005.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022588477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0264-410X(14)01081-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Laprise, Jean-François</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anogenital warts</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunisation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human papillomavirus (HPV)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccine schedules</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Transmission-dynamic modelling</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Programme optimisation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cost-effectiveness</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Drolet, Mélanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boily, Marie-Claude</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jit, Mark</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sauvageau, Chantal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franco, Eduardo L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lemieux-Mellouki, Philippe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malagón, Talía</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brisson, Marc</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Li, Yaoyao ELSEVIER</subfield><subfield code="t">Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV007884451</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:44</subfield><subfield code="g">day:7</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:5845-5853</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.vaccine.2014.07.099</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.00</subfield><subfield code="j">Land- und Forstwirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2014</subfield><subfield code="e">44</subfield><subfield code="b">7</subfield><subfield code="c">1007</subfield><subfield code="h">5845-5853</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Laprise, Jean-François |
spellingShingle |
Laprise, Jean-François ddc 610 ddc 630 bkl 48.00 Elsevier Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study |
authorStr |
Laprise, Jean-François |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007884451 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 630 - Agriculture & related technologies 640 - Home & family management |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 630 640 VZ 48.00 bkl Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer Elsevier |
topic |
ddc 610 ddc 630 bkl 48.00 Elsevier Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer |
topic_unstemmed |
ddc 610 ddc 630 bkl 48.00 Elsevier Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer |
topic_browse |
ddc 610 ddc 630 bkl 48.00 Elsevier Anogenital warts Elsevier Immunisation Elsevier Human papillomavirus (HPV) Elsevier Vaccine schedules Elsevier Transmission-dynamic modelling Elsevier Programme optimisation Elsevier Cost-effectiveness Elsevier Cervical cancer |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m d md m c b mcb m j mj c s cs e l f el elf p l m plm t m tm m b mb |
hierarchy_parent_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
hierarchy_parent_id |
ELV007884451 |
dewey-tens |
610 - Medicine & health 630 - Agriculture 640 - Home & family management |
hierarchy_top_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV007884451 |
title |
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study |
ctrlnum |
(DE-627)ELV022588477 (ELSEVIER)S0264-410X(14)01081-0 |
title_full |
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study |
author_sort |
Laprise, Jean-François |
journal |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
journalStr |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
5845 |
author_browse |
Laprise, Jean-François |
container_volume |
32 |
physical |
9 |
class |
610 610 DE-600 630 640 VZ 48.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Laprise, Jean-François |
doi_str_mv |
10.1016/j.vaccine.2014.07.099 |
dewey-full |
610 630 640 |
title_sort |
comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study |
title_auth |
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study |
abstract |
• 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. |
abstractGer |
• 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. |
abstract_unstemmed |
• 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR |
container_issue |
44 |
title_short |
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study |
url |
https://doi.org/10.1016/j.vaccine.2014.07.099 |
remote_bool |
true |
author2 |
Drolet, Mélanie Boily, Marie-Claude Jit, Mark Sauvageau, Chantal Franco, Eduardo L. Lemieux-Mellouki, Philippe Malagón, Talía Brisson, Marc |
author2Str |
Drolet, Mélanie Boily, Marie-Claude Jit, Mark Sauvageau, Chantal Franco, Eduardo L. Lemieux-Mellouki, Philippe Malagón, Talía Brisson, Marc |
ppnlink |
ELV007884451 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.vaccine.2014.07.099 |
up_date |
2024-07-06T16:39:57.815Z |
_version_ |
1803848513298104320 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022588477</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164301.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.vaccine.2014.07.099</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014008000005.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022588477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0264-410X(14)01081-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Laprise, Jean-François</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• 2-dose girls-only HPV vaccination is likely to be cost-effective if protection is at least 10 years. • A 3rd dose is unlikely to be cost-effective if 2-dose duration of protection is longer than 30 years. • Vaccinating boys is unlikely to be cost-effective unless the cost/dose is substantially reduced.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anogenital warts</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunisation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human papillomavirus (HPV)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccine schedules</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Transmission-dynamic modelling</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Programme optimisation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cost-effectiveness</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Drolet, Mélanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boily, Marie-Claude</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jit, Mark</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sauvageau, Chantal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franco, Eduardo L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lemieux-Mellouki, Philippe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malagón, Talía</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brisson, Marc</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Li, Yaoyao ELSEVIER</subfield><subfield code="t">Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV007884451</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:44</subfield><subfield code="g">day:7</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:5845-5853</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.vaccine.2014.07.099</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.00</subfield><subfield code="j">Land- und Forstwirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2014</subfield><subfield code="e">44</subfield><subfield code="b">7</subfield><subfield code="c">1007</subfield><subfield code="h">5845-5853</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4012003 |